EHA 2019: Clinical benefit of daratumumab plus standard of care in transplant-eligible NDMM patients

Phillippe Moreau | | KESÄKUU 17, 2019

Asiantuntija: Phillippe Moreau

Click and hear Philippe Moreau present the data from CASSIOPEIA study - the first study to demonstrate the clinical benefit of daratumumab plus standard of care in transplant-eligible NDMM patients.